{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:06:40Z","timestamp":1785769600923,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"\"Six One Projects\" for High-level Health Talents by Jiangsu Commission of Health","award":["LGY2017020"],"award-info":[{"award-number":["LGY2017020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic HBV infection, the main cause of liver cirrhosis and hepatocellular carcinoma, has become a global health concern. Machine learning algorithms are particularly adept at analyzing medical phenomenon by capturing complex and nonlinear relationships in clinical data. Our study proposed a predictive model on the basis of 55 routine laboratory and clinical parameters by machine learning algorithms as a novel non-invasive method for liver fibrosis diagnosis. The model was further evaluated on the accuracy and rationality and proved to be highly accurate and efficient for the prediction of HBV-related fibrosis. In conclusion, we suggested a potential combination of high-dimensional clinical data and machine learning predictive algorithms for the liver fibrosis diagnosis.<\/jats:p>","DOI":"10.1038\/s41598-021-84556-4","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T06:02:36Z","timestamp":1614751356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["High-dimensional hepatopath data analysis by machine learning for predicting HBV-related fibrosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Xiangke","family":"Pu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianle","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"key":"84556_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","volume":"30","author":"JJ Ott","year":"2012","unstructured":"Ott, J. J., Stevens, G. A., Groeger, J. & Wiersma, S. T. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30, 2212\u20132219. https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.116 (2012).","journal-title":"Vaccine"},{"key":"84556_CR2","doi-asserted-by":"publisher","first-page":"S158","DOI":"10.1097\/00004836-200411003-00008","volume":"38","author":"B Custer","year":"2004","unstructured":"Custer, B. et al. Global epidemiology of hepatitis B virus. J. Clin. Gastroenterol. 38, S158-168 (2004).","journal-title":"J. Clin. Gastroenterol."},{"key":"84556_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22341","author":"X Wu","year":"2017","unstructured":"Wu, X. et al. Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B. J. Clin. Lab. Anal. https:\/\/doi.org\/10.1002\/jcla.22341 (2017).","journal-title":"J. Clin. Lab. Anal."},{"key":"84556_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/cpf.12297","volume":"37","author":"M Thiele","year":"2017","unstructured":"Thiele, M., Kjaergaard, M., Thielsen, P. & Krag, A. Contemporary use of elastography in liver fibrosis and portal hypertension. Clin. Physiol. Funct. Imaging 37, 235\u2013242. https:\/\/doi.org\/10.1111\/cpf.12297 (2017).","journal-title":"Clin. Physiol. Funct. Imaging"},{"key":"84556_CR5","doi-asserted-by":"publisher","first-page":"46732","DOI":"10.1038\/srep46732","volume":"7","author":"Y Yamamoto","year":"2017","unstructured":"Yamamoto, Y. et al. Quantitative diagnosis of breast tumors by morphometric classification of microenvironmental myoepithelial cells using a machine learning approach. Sci. Rep. 7, 46732. https:\/\/doi.org\/10.1038\/srep46732 (2017).","journal-title":"Sci. Rep."},{"key":"84556_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/apt.14172","volume":"46","author":"TC Yip","year":"2017","unstructured":"Yip, T. C. et al. Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population. Aliment. Pharmacol. Ther. 46, 447\u2013456. https:\/\/doi.org\/10.1111\/apt.14172 (2017).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"84556_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","volume":"163","author":"D Zeevi","year":"2015","unstructured":"Zeevi, D. et al. Personalized nutrition by prediction of glycemic responses. Cell 163, 1079\u20131094. https:\/\/doi.org\/10.1016\/j.cell.2015.11.001 (2015).","journal-title":"Cell"},{"key":"84556_CR8","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMp1702071","volume":"376","author":"JH Chen","year":"2017","unstructured":"Chen, J. H. & Asch, S. M. Machine learning and prediction in medicine\u2014beyond the peak of inflated expectations. N Engl. J. Med. 376, 2507\u20132509. https:\/\/doi.org\/10.1056\/NEJMp1702071 (2017).","journal-title":"N Engl. J. Med."},{"key":"84556_CR9","doi-asserted-by":"publisher","unstructured":"Chinese Society of Infectious Diseases, C. M. A. & Chinese Society of Hepatology, C. M. A. [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)]. Zhonghua Gan Zang Bing Za Zhi 27, 938\u2013961, https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2019.12.007 (2019).","DOI":"10.3760\/cma.j.issn.1007-3418.2019.12.007"},{"key":"84556_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa, P. & Poynard, T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24, 289\u2013293. https:\/\/doi.org\/10.1002\/hep.510240201 (1996).","journal-title":"Hepatology"},{"key":"84556_CR11","doi-asserted-by":"publisher","first-page":"17413","DOI":"10.1038\/srep17413","volume":"5","author":"Q Zhang","year":"2015","unstructured":"Zhang, Q. et al. Epidemiology study of HBV genotypes and antiviral drug resistance in multi-ethnic regions from Western China. Sci. Rep. 5, 17413. https:\/\/doi.org\/10.1038\/srep17413 (2015).","journal-title":"Sci. Rep."},{"key":"84556_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15040661","author":"B Zhu","year":"2018","unstructured":"Zhu, B., Liu, J., Fu, Y., Zhang, B. & Mao, Y. Spatio-temporal epidemiology of viral hepatitis in China (2003\u20132015): implications for prevention and control policies. Int. J. Environ. Res. Public Health. https:\/\/doi.org\/10.3390\/ijerph15040661 (2018).","journal-title":"Int. J. Environ. Res. Public Health."},{"key":"84556_CR13","doi-asserted-by":"publisher","first-page":"22944","DOI":"10.18632\/oncotarget.14430","volume":"8","author":"Z Yin","year":"2017","unstructured":"Yin, Z., Zou, J., Li, Q. & Chen, L. Diagnostic value of FIB-4 for liver fibrosis in patients with hepatitis B: a meta-analysis of diagnostic test. Oncotarget 8, 22944\u201322953. https:\/\/doi.org\/10.18632\/oncotarget.14430 (2017).","journal-title":"Oncotarget"},{"key":"84556_CR14","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S2468-1253(19)30087-1","volume":"4","author":"MJ Sonneveld","year":"2019","unstructured":"Sonneveld, M. J. et al. Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study. Lancet Gastroenterol. Hepatol. 4, 538\u2013544. https:\/\/doi.org\/10.1016\/S2468-1253(19)30087-1 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"84556_CR15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/17474124.2019.1653757","volume":"13","author":"GP Milas","year":"2019","unstructured":"Milas, G. P., Karageorgiou, V. & Cholongitas, E. Red cell distribution width to platelet ratio for liver fibrosis: a systematic review and meta-analysis of diagnostic accuracy. Expert. Rev. Gastroenterol. Hepatol. 13, 877\u2013891. https:\/\/doi.org\/10.1080\/17474124.2019.1653757 (2019).","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"84556_CR16","doi-asserted-by":"publisher","first-page":"7089702","DOI":"10.1155\/2017\/7089702","volume":"2017","author":"T Ren","year":"2017","unstructured":"Ren, T., Wang, H., Wu, R. & Niu, J. Gamma-glutamyl transpeptidase-to-platelet ratio predicts significant liver fibrosis of chronic hepatitis B patients in China. Gastroenterol. Res. Practice 2017, 7089702. https:\/\/doi.org\/10.1155\/2017\/7089702 (2017).","journal-title":"Gastroenterol. Res. Practice"},{"key":"84556_CR17","first-page":"759","volume":"100","author":"A Smith","year":"2019","unstructured":"Smith, A., Baumgartner, K. & Bositis, C. Cirrhosis: diagnosis and management. Am. Fam. Physician 100, 759\u2013770 (2019).","journal-title":"Am. Fam. Physician"},{"key":"84556_CR18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1177\/2050640619865133","volume":"7","author":"K Staufer","year":"2019","unstructured":"Staufer, K. et al. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. United Eur. Gastroenterol. J. 7, 1113\u20131123. https:\/\/doi.org\/10.1177\/2050640619865133 (2019).","journal-title":"United Eur. Gastroenterol. J."},{"key":"84556_CR19","doi-asserted-by":"publisher","first-page":"100067","DOI":"10.1016\/j.jhepr.2020.100067","volume":"2","author":"K Patel","year":"2020","unstructured":"Patel, K. & Sebastiani, G. Limitations of non-invasive tests for assessment of liver fibrosis. JHEP Rep. 2, 100067. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100067 (2020).","journal-title":"JHEP Rep."},{"key":"84556_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1089\/omi.2019.0035","volume":"23","author":"B Lin","year":"2019","unstructured":"Lin, B. et al. Novel serum biomarkers for noninvasive diagnosis and screening of nonalcoholic fatty liver disease-related hepatic fibrosis. OMICS 23, 181\u2013189. https:\/\/doi.org\/10.1089\/omi.2019.0035 (2019).","journal-title":"OMICS"},{"key":"84556_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-018-1136-2","author":"L Yan","year":"2018","unstructured":"Yan, L. et al. Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT. Infection https:\/\/doi.org\/10.1007\/s15010-018-1136-2 (2018).","journal-title":"Infection"},{"key":"84556_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010040","author":"N Tamaki","year":"2020","unstructured":"Tamaki, N. et al. Wisteria floribunda agglutinin-positive mac-2 binding protein as a screening tool for significant liver fibrosis in health checkup. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22010040 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"84556_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/hepr.13468","volume":"50","author":"M Takatsuki","year":"2020","unstructured":"Takatsuki, M. et al. Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker of liver fibrosis in human immunodeficiency virus\/hepatitis C virus coinfected patients. Hepatol Res. 50, 419\u2013425. https:\/\/doi.org\/10.1111\/hepr.13468 (2020).","journal-title":"Hepatol Res."},{"key":"84556_CR24","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41374-020-0425-4","volume":"100","author":"Z Du","year":"2020","unstructured":"Du, Z. et al. SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin alpha5beta1\/PI3K\/Akt signaling pathway. Lab. Invest. 100, 1042\u20131056. https:\/\/doi.org\/10.1038\/s41374-020-0425-4 (2020).","journal-title":"Lab. Invest."},{"key":"84556_CR25","doi-asserted-by":"publisher","first-page":"860","DOI":"10.5009\/gnl16560","volume":"11","author":"S Bao","year":"2017","unstructured":"Bao, S. et al. Serum MicroRNA levels as a noninvasive diagnostic biomarker for the early diagnosis of hepatitis B virus-related liver fibrosis. Gut Liver 11, 860\u2013869. https:\/\/doi.org\/10.5009\/gnl16560 (2017).","journal-title":"Gut Liver"},{"key":"84556_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/jb\/mvaa074","volume":"168","author":"X Gong","year":"2020","unstructured":"Gong, X., Wang, X. & Zhou, F. Liver microRNA-29b-3p positively correlates with relative enhancement values of magnetic resonance imaging and represses liver fibrosis. J. Biochem. 168, 603\u2013609. https:\/\/doi.org\/10.1093\/jb\/mvaa074 (2020).","journal-title":"J. Biochem."}],"updated-by":[{"DOI":"10.1038\/s41598-021-96032-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84556-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84556-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84556-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T23:36:37Z","timestamp":1670024197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84556-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["84556"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-84556-4","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-021-96032-0","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]},"assertion":[{"value":"16 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-021-96032-0","URL":"https:\/\/doi.org\/10.1038\/s41598-021-96032-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5081"}}